Clinical Trial Update: Evaluation of TEG 6S PM® During Cardiopulmonary Bypass to Detect Postoperative Biological Coagulopathy

View source ↗

Summary

A completed clinical trial evaluated the TEG 6S PM device during cardiopulmonary bypass to detect postoperative coagulopathy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coagulopathy

Snippet

Sponsor: University Hospital, Montpellier | Conditions: Coagulopathy, Cardiopulmonary Bypass | Status: COMPLETED